Cargando…

Predictors of Hematologic Malignancy Relapse in Patients with Advanced Chronic Graft-versus-Host Disease

Malignancy relapse remains a major barrier to treatment success in patients after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Chronic graft-versus-host disease (cGVHD) markedly reduces hematologic malignancy relapse risk, but relapses still occur in these patients. Patients (n=27...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruben, Claire L., Pirsl, Filip, Steinberg, Seth M., Holtzman, Noa G., Parsons-Wandell, Laura, Baruffaldi, Judy, Curtis, Lauren M., Mitchell, Sandra A., Kerep, Ana Zelic, Cowen, Edward W., Berger, Ann, Joe, Galen O., Datiles, Manuel B., Mays, Jacqueline W., Pavletic, Steven Z.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555869/ https://www.ncbi.nlm.nih.gov/pubmed/33526918 http://dx.doi.org/10.1038/s41409-021-01211-2

Ejemplares similares

Determinants and Clinical Significance of Musculoskeletal Symptoms in Patients With Chronic Graft-Versus-Host Disease
por: Zelic Kerep, Ana, et al.
Publicado: (2022)

Clinical Characterization and Cytokine Profile of Fatigue in Hematologic Malignancy Patients with Chronic Graft-Versus-Host Disease
por: Goklemez, Sencer, et al.
Publicado: (2021)

Vitamin D levels and their associations with survival and major disease outcomes in a large cohort of patients with chronic graft-vs-host disease
por: Katić, Mašenjka, et al.
Publicado: (2016)

Chronic gvhd dictionary—eurograft cost action initiative consensus report
por: Zelić Kerep, Ana, et al.
Publicado: (2022)

Immunotherapy in hematologic malignancies: past, present, and future
por: Im, Annie, et al.
Publicado: (2017)

Bilious Typhus Relapsing Fever
por: McCowen, W. T.
Publicado: (1906)

Achalasia in a Patient Undergoing Hematologic Stem Cell Transplant After Exposure to Tacrolimus
por: Goklemez, Sencer, et al.
Publicado: (2017)

Collection of peripheral blood mononucleated cells for chronic graft-versus-host disease immunology research: safety and effectiveness of leukapheresis in 132 patients
por: Mina, Alain, et al.
Publicado: (2022)

Significant Associations of IgG Glycan Structures With Chronic Graft-Versus-Host Disease Manifestations: Results of the Cross-Sectional NIH Cohort Study
por: Prenc, Ema, et al.
Publicado: (2021)

Congenital Cataracts: Classification and Association With Anterior Segment Abnormalities
por: Datiles, Manuel B., et al.
Publicado: (2016)

Relapse and Resistance to CAR-T Cells and Blinatumomab in Hematologic Malignancies
por: Jacoby, Elad
Publicado: (2019)

HPV32‐related Heck’s disease in a chronic graft‐versus‐host disease patient with long‐term successful KTP laser treatment: A rare case report
por: Nguyen, Joe Truong, et al.
Publicado: (2021)

The ISHLT chronic lung allograft dysfunction consensus criteria are applicable to pulmonary chronic graft-versus-host disease
por: Pang, Yifan, et al.
Publicado: (2022)

A starting point for the phenotypic classification of pulmonary chronic graft-versus-host disease
por: Pang, Yifan, et al.
Publicado: (2022)

Adverse Hematological and Non-Hematological Events in Patients With Relapsed/Refractory Multiple Myeloma That Are Responsive to Daratumumab, Pomalidomide and Dexamethasone
por: Alkharabsheh, Omar, et al.
Publicado: (2023)

Ocular surface indicators and biomarkers in chronic ocular graft-versus-host disease: a prospective cohort study
por: Pietraszkiewicz, Alexandra A., et al.
Publicado: (2021)

B regulatory cells and monocyte subpopulations in patients with chronic graft-vs-host disease
por: Babić, Antonija, et al.
Publicado: (2021)

Molecular and hematologic relapses in adult patients with acute promyelocytic leukemia: a cohort study
por: Azevedo, Ilana de França, et al.
Publicado: (2017)

Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis
por: Premkumar, Vikram J., et al.
Publicado: (2021)

Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies
por: Pavletic, ZS, et al.
Publicado: (1998)

Hematology and Hemostasis
por: Finke, Jürgen, et al.
Publicado: (2008)

A Phase I/II Open-Label Study of Molibresib for the Treatment of Relapsed/Refractory Hematologic Malignancies
por: Dawson, Mark A., et al.
Publicado: (2023)

Reverse Pseudohyperkalemia: An Important Clinical Entity in Chronic Lymphocytic Leukemia
por: Mansoor, Sahar, et al.
Publicado: (2015)

Chronic graft-versus-host disease is characterized by high levels and distinctive tissue-of-origin patterns of cell-free DNA
por: Pang, Yifan, et al.
Publicado: (2023)

Patient-reported outcomes in patients with hematological relapse or progressive disease: a longitudinal observational study
por: Sommer, Mia, et al.
Publicado: (2021)

Lectures on Hematology
por: Hollingsworth, J. W.
Publicado: (1961)

Prolonged complete hematologic response in relapsed/refractory T-large granular lymphocyte leukemia after bendamustine treatment
por: Rosamilio, R., et al.
Publicado: (2016)

Quantitative Salivary Proteomic Differences in Oral Chronic Graft-versus-Host Disease
por: Bassim, Carol W, et al.
Publicado: (2012)

P1543: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH HEMATOLOGICAL MALIGNANCIES THAT NEED VASOACTIVE SUPPORT – SINGLE CENTER STUDY
por: Vitkon, Roy, et al.
Publicado: (2023)

Introduction to Veterinary Hematology
por: Harvey, John W.
Publicado: (2012)

Cyclodextrin-Based Displacement Strategy of Sterigmatocystin from Serum Albumin as a Novel Approach for Acute Poisoning Detoxification
por: Jakšić, Daniela, et al.
Publicado: (2023)

Relapsing Fever Infection Manifesting as Aseptic Meningitis, Texas, USA
por: Ellis, Lisa, et al.
Publicado: (2021)

Donor lymphocyte infusion for prevention of relapse after unmanipulated haploidentical PBSCT for very high-risk hematologic malignancies
por: Gao, Xiao-Ning, et al.
Publicado: (2018)

Venetoclax plus hypomethylating agents versus intensive chemotherapy for hematological relapse of myeloid malignancies after allo-HSCT
por: Chen, Zhangjie, et al.
Publicado: (2023)

Tickborne Relapsing Fever, Jerusalem, Israel, 2004–2018
por: Hashavya, Saar, et al.
Publicado: (2020)

Synergy of Microtechnology and Biotechnology: Microreactors as an Effective Tool for Biotransformation Processes(§): (§)The paper was presented at European Biotechnology Congress, 25-27 May 2017, Dubrovnik, Croatia
por: Šalić, Anita, et al.
Publicado: (2018)

Thermodynamically consistent derivation of chemical potential of a battery solid particle from the regular solution theory applied to LiFePO(4)
por: Zelič, Klemen, et al.
Publicado: (2019)

Editorial: Linking cellular metabolism to hematological malignancies
por: He, Xiujing, et al.
Publicado: (2022)

Clustered precursors in bone marrow sections predict early relapse in patients with acute myeloid leukemia within hematologic remission
por: Yu, Yehua, et al.
Publicado: (2014)

Recipient ADAMTS13 Single-Nucleotide Polymorphism Predicts Relapse after Unrelated Bone Marrow Transplantation for Hematologic Malignancy
por: Nomoto, Haruka, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ai9drajhu7avt1vgscdtiq4a62